How Our Insulin Affordability Programs Help People

Lilly offers several insulin affordability programs to fill gaps in the current health care system for people most likely to pay higher out-of-pocket amounts for their medicines. This includes people in high-deductible health insurance plans, the uninsured, and seniors or disabled people in Medicare Part D.

In fact, of the 1.4 million people in the United States who take Lilly's most commonly prescribed diabetes medicines, only 1 in 20 people pay more than $95 month. A large majority (90%) pay $50 or less a month. 

Here’s a closer look at our affordability solutions:

Capping Out-of-Pocket Costs
For more than a year, Lilly has capped out-of-pocket costs at $95 per month. This cap applies to people with or without private insurance. And the $95 cap applies to an entire month’s prescription – not just one vial, or one pen.

Lower Price Medicine
We also have a lower price version of our most commonly prescribed diabetes medicine. It can be ordered by any pharmacy from several wholesalers and will usually be delivered in 1-2 days. If for any reason you cannot get it through your pharmacy, you should call the Lilly Diabetes Solution Center at (833) 808-1234.

Lilly Diabetes Solution Center
Each month this year, up to 20,000 people get help via the Lilly Diabetes Solution Center. The Lilly Diabetes Solution Center offers affordability solutions, donations to free clinics across the U.S., and other options to support people with immediate need for diabetes medication. Our patient-focused hotline staffed by medical representatives in the U.S. is available Monday through Friday, 9 a.m. – 8 p.m. Eastern time. Anyone can call the Lilly Diabetes Solution Center at (833) 808-1234 to find out if they’re getting the lowest possible price based on their eligibility. PhRMA’s Medicine Assistance Tool (MAT) is another resource for patients, caregivers, and health providers. MAT is a search engine to help people learn more about the resources available through various biopharmaceutical industry programs.

Our programs are helping people, but there’s more work to be done. We’re actively working with key stakeholders to seek long-term policy changes to address the gaps in our health care system, and we’re confident solutions are possible.